After unanimously voting to recommend a miraculous hepatitis C drug for approval in 2013, a panel of experts advising the Food and Drug Administration gushed about what they’d accomplished.
There’s no doubt that surgically implanted medical devices can improve lives.
Hip and knee replacements can help people regain their mobility. Drug pumps can deliver doses of pain-relieving medicine on demand. And metal rods can stabilize spines and broken bones.
With prescription drug prices soaring and President Donald Trump vowing to take action, an old idea is gaining fresh traction: allowing Americans to buy medicines from foreign pharmacies at far lower prices.
The Food and Drug Administration removed an obstacle from of its “compassionate use” policy this month, eliminating some paperwork that physicians must do to obtain experimental drugs for some patients with immediately life-threatening illnesses.
At some hospitals, posters on the wall in the emergency department list the drugs that are in short supply or unavailable, along with recommended alternatives.
Vancouver, WASHINGTON – September 10, 2015 – "In previously documented studies, injecting PRO 140 has reduced viral loads by as much as 2.5log and 1.8log.
The Pharmaceutical Research and Manufacturers of America is asking for a midstream change to legislation that allows the Oregon Health Authority to deny payment for high-priced blockbuster drugs for six months after they’ve been approved by the U.S. Food and Drug Administration.
The House Health Committee greenlighted the libertarian “right-to-try” initiative, sending an amended House Bill 2300 to the floor on a unanimous vote.
This article is for premium subscribers!
To read further, please sign up for a premium subscription. You can also read more about standard and premium subscriptions here. Your subscription dollars are tax deductible and support the in-depth stories you appreciate from The Lund Report. If you believe you already are a premium subscriber, you are already logged in, and you are getting this message, please contact [email protected] Thanks!
If you are a premium subscriber that is not logged in, please login now.
The out-of-control and arbitrary pricing of designer prescription drugs dominated the House Health Committee on Monday, with three bills aimed at helping consumers, the state and health insurers to address the problem.